Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
50.45%
Operating Margin
0.00%
Net Margin
-3.97%
Efficiency Metrics
Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
9.16%
Income Tax Rate
106,200,000.0%
EPS
-0.1200000000
Balance Sheet Analysis
Current Ratio
5.08
Cash Ratio
0.40
Working Capital
$2.65B
Debt to Equity
2.14
Debt to Assets
65.24%
Equity Ratio
30.43%
Cash Flow Analysis
Operating Cash Flow Ratio
35.10%
Free Cash Flow Ratio
33.30%
CapEx to Revenue
1.80%
Dividends Paid
$103.95M
Stock Buybacks
$2.89M
Total Shareholder Returns
$106.84M
Cash Position Change
-9.21%
Key Takeaways (2023 FY)
Increased dividend payments by 4.79%
Detailed Growth Metrics
Core Performance
Revenue
9.36%
Net Income
-133.96%
EPS
-134.29%
Operating Income
-100.00%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
8.33%
Operating Cash Flow
9.86%
Free Cash Flow
13.45%
Balance Sheet Health
Assets
-11.62%
Debt
-14.15%
Book Value per Share
-7.78%
Inventory
0.00%
Shareholder Returns
Dividends per Share
4.79%
Shares Outstanding
-0.19%
Long Term Trends
3Y Revenue/Share
-6.52%
5Y Revenue/Share
-21.33%
3Y Dividend/Share
103.39%
5Y Dividend/Share
-46.72%